Drug Parkinsons Disease Psychosis

Nuplazid

Payments companies reported to CMS as associated with Nuplazid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$7.2Massociated payments (2023-2025)
12,383clinicians with associated payments
1company reporting

By year

2023 $2.9M
2024 $2.2M
2025 $2.1M

Payments reported as associated with Nuplazid, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $3.7M
Psychiatry $1.0M
Psychiatric/Mental Health (Nurse Practitioner) $432K
Family $374K
Geriatric Medicine (Family Medicine) $257K
Nurse Practitioner $222K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Nuplazid

These are the largest totals companies reported as associated with Nuplazid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Fahd Amjad Washington, DC Neurology (Psychiatry & Neurology) $236,859.22
Cherian Karunapuzha Oklahoma City, OK Neurology (Psychiatry & Neurology) $221,483.30
David Kreitzman Commack, NY Neurology (Psychiatry & Neurology) $210,538.98
Mazhar Khowaja Houston, TX Psychiatry $196,576.07
Stuart Isaacson Boca Raton, FL Neurology (Psychiatry & Neurology) $176,198.90
Zoltan Mari Las Vegas, NV Neurology (Psychiatry & Neurology) $159,545.52
Daniel Cannone Wadsworth, OH Geriatric Medicine (Family Medicine) $143,630.11
Laxman Bahroo Washington, DC Neurology (Psychiatry & Neurology) $143,020.15
Phyillis Kennedy-Howell Barney, GA Psychiatric/Mental Health (Nurse Practitioner) $138,455.96
Albert Riddle Haworth, NJ Geriatric Medicine (Internal Medicine) $136,032.45

Prescribed Nuplazid?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.